Targeted delivery of rosuvastatin enhances treatment of HHcy-induced atherosclerosis using macrophage membrane-coated nanoparticles-Reference-Cited by-同舟云学术

Targeted delivery of rosuvastatin enhances treatment of HHcy-induced atherosclerosis using macrophage membrane-coated nanoparticles

Published:2024-01 Issue: Volume: Page:
ISSN:2095-1779
Container-title:Journal of Pharmaceutical Analysis
language:en
Short-container-title:Journal of Pharmaceutical Analysis

Author:

Liu Dayue,Yang Anning,Li Yulin,Li Zhenxian,You Peidong,Zhang Hongwen,Quan Shangkun,Sun Yue,Zeng Yaling,Ma Shengchao,Xiong Jiantuan,Hao Yinju,Li Guizhong,Liu Bin,Zhang Huiping,Jiang Yideng

Funder

National Natural Science Foundation of China

Ningxia Hui Autonomous Region Natural Science Foundation

Publisher

Elsevier BV

Reference51 articles.

1. The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis;Zhang;Atherosclerosis,2021

2. Impact of macrophages in atherosclerosis;Lu;Curr. Med. Chem.,2016

3. Acute Liver Injury in a Patient Treated With Rosuvastatin: A Rare Adverse Effect;Shah;Gastroenterology Res,2019

4. Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review, Biomed;Cheraghi;Pharmacother,2017

5. Progress in applications of Prussian blue nanoparticles in biomedicine;Qin;Adv. Healthc. Mater.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancement of Indocyanine Green Based Nanotheranostics for Imaging and Therapy of Coronary Atherosclerosis;Molecular Pharmaceutics;2024-09-03

2. Biomimetic Oil-in-Water Nanoemulsions as a Suitable Drug Delivery System to Target Inflamed Endothelial Cells;Nanomaterials;2024-07-31